美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

BlossomHill Therapeutics

16.38

+0.58003.67%

盘后：16.380.00000.00%19:30 EDT

成交量：11.14万

成交额：180.68万

市值：5.02亿

市盈率：-6.70

高：16.50

开：16.00

低：15.75

收：15.80

52周最高：17.25

52周最低：15.25

股本：3,064.37万

流通股本：937.50万

量比：0.45

换手率：1.19%

股息：- -

股息率：- -

每股收益(TTM):-2.4440

每股收益(LYR):-24.8342

净资产收益率：--

总资产收益率：--

市净率：-3.30

市盈率(LYR):-0.66

数据加载中...

总览公司新闻资讯公告

Blossomhill Therapeutics宣布其宏环Omni-Egfr™抑制剂Bh-30643获FDA快速通道资格，用于治疗晚期EGFR C797S突变非小细胞肺癌

美股异动 | BlossomHill Therapeutics(BLSM.US)登陆美股市场开盘后股价小幅走低

BlossomHill Therapeutics 1.5亿美元增额IPO后料平淡上市

小分子抗癌疗法开发商BlossomHill(BLSM.US)IPO定价15-17美元/股拟筹资1.25亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BLSM/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"BlossomHill Therapeutics","latestPrice":16.38,"timestamp":1787342400000,"preClose":15.8,"halted":0,"volume":111393,"hourTrading":{"tag":"盘后","latestPrice":16.38,"preClose":16.38,"latestTime":"19:30 EDT","volume":19,"amount":307.42,"timestamp":1787355008098,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03670886075949356,"floatShares":9375000,"shares":30643700,"eps":-2.444,"marketStatus":"休市中","change":0.58,"latestTime":"08-21 16:00:00 EDT","open":16,"high":16.5,"low":15.75,"amount":1806784.4346299998,"amplitude":0.047468,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":15.8,"postHourTrading":{"tag":"盘后","latestPrice":16.38,"preClose":16.38,"latestTime":"19:30 EDT","volume":19,"amount":307.42,"timestamp":1787355008098,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4536184656458545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":0.4536184656458545,"shares":30643700,"dividePrice":0,"high":16.5,"amplitude":0.047468,"preClose":15.8,"low":15.75,"week52Low":15.25,"pbRate":"-3.30","week52High":17.2488,"institutionHeld":0,"latestPrice":16.38,"eps":-2.444,"divideRate":0,"volume":111393,"delay":0,"ttmEps":-2.444,"open":16,"prevYearClose":16,"prevWeekClose":16.18,"prevMonthClose":16,"prevQuarterClose":16,"fiveDayClose":16.18,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-08-21","current":-6.702128,"percent":0.909091,"low":-7.12152,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"high":-2.788792,"avg":-6.617124,"sd":1.157195,"marketCap":484169828},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828}],"updateTime":1787515995768},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1162137187","title":"Blossomhill Therapeutics宣布其宏环Omni-Egfr™抑制剂Bh-30643获FDA快速通道资格，用于治疗晚期EGFR C797S突变非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1162137187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162137187?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 19:01","pubTimestamp":1787050871,"startTime":"0","endTime":"0","summary":"Blossomhill Therapeutics今日宣布，美国食品药品监督管理局已授予其候选药物Bh-30643快速通道资格。该药物是一种宏环Omni-Egfr抑制剂，专为治疗携带EGFR C797S突变的晚期非小细胞肺癌患者而设计。这一资格认定意味着Bh-30643有望加速开发和审评进程，以应对当前未被满足的医疗需求。EGFR C797S突变常被视为对现有靶向治疗产生耐药性的关键机制之一，临床挑战严峻。Blossomhill Therapeutics表示，获得快速通道资格是其推进创新疗法过程中的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640472","title":"美股异动 | BlossomHill Therapeutics(BLSM.US)登陆美股市场 开盘后股价小幅走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640472?lang=zh_cn&edition=fundamental","pubTime":"2026-08-08 00:00","pubTimestamp":1786118400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，BlossomHill Therapeutics登陆美股市场，截至发稿，该股跌超1%，报15.8美元。BlossomHill Therapeutics总部位于加州圣地亚哥，成立于2020年。该公司专注于通过识别现有治疗方法中的结构性弱点，并设计新的化合物来克服这些弱点，从而开发小分子癌症药物。公司计划于2026年第四季度与美国食品药品监督管理局举行一期临床结束会议，讨论推荐的二期临床给药方案，以及针对部分患者潜在的加速批准路径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLSM","BK4539","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657264457","title":"BlossomHill Therapeutics 1.5亿美元增额IPO后料平淡上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2657264457","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657264457?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 22:24","pubTimestamp":1786112666,"startTime":"0","endTime":"0","summary":"BUZZ-BlossomHill Therapeutics 1.5亿美元增额IPO后料平淡上市8月7日-** 药物开发商BlossomHill Therapeutics在1.5亿美元增额IPO后，纳斯达克首日上市预计将持平开盘** 该股最新显示开盘价为每股16.05美元，而发行价为16美元** 总部位于加利福尼亚州圣地亚哥的BLSM公司通过规模扩大的首次公开募股，以每股16美元的价格售出约940万股 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4T44417W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM","MNSH","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656536749","title":"小分子抗癌疗法开发商BlossomHill(BLSM.US)IPO定价15-17美元/股 拟筹资1.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656536749","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656536749?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 16:47","pubTimestamp":1785833278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UDN","UUP","IPOS","BLSM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}